Myelofibrosis laboratory tests: Difference between revisions

Jump to navigation Jump to search
Line 12: Line 12:
* Raised levels of [[lactate dehydrogenase]]
* Raised levels of [[lactate dehydrogenase]]
* Raised neutrophil alkaline phosphatase score
* Raised neutrophil alkaline phosphatase score
====TB testing====
The patient with the myelofibrosis should be tested for [[Tuberculosis]] even if the patient doesn't manifest the symptoms of TB. There is strong evidence of myelofibrois improvement with the antituberculous treatment.


==References==
==References==

Revision as of 18:06, 22 January 2012

Myelofibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelofibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myelofibrosis laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myelofibrosis laboratory tests

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myelofibrosis laboratory tests

CDC on Myelofibrosis laboratory tests

Myelofibrosis laboratory tests in the news

Blogs on Myelofibrosis laboratory tests

Directions to Hospitals Treating Myelofibrosis

Risk calculators and risk factors for Myelofibrosis laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory Tests

Diagnosis is based upon:

TB testing

The patient with the myelofibrosis should be tested for Tuberculosis even if the patient doesn't manifest the symptoms of TB. There is strong evidence of myelofibrois improvement with the antituberculous treatment.

References


Template:WikiDoc Sources